Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-20

Clinical Trial Update: Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)

View source ↗

Summary

The trial examined whether esophageal mast cell activation contributes to noncardiac chest pain (NCCP). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Noncardiac Chest Pain (NCCP) | Status: COMPLETED